The level of repeat business and positive feedback from existing clients
is testament to the quality of oncology drug development services
Nexus Oncology
consistently deliver.
     
 

Addition of Russian Sites Ensures Patient Recruitment Targets are Met by Nexus Oncology
more >>

Nexus Achieves Impressive Recruitment rates in Very Rare Tumour Indication
more >>

Nexus Awarded a Programme of Phase I Studies by Existing Sponsor
more >>

Nexus Oncology Expands to North America with Repeat Business Win From Existing Sponsor
more >>

Nexus Oncology Successfully Executes Phase III Registration Study for Biotech Sponsor with First in Class Molecule
more >>

Successful Phase I Study Leads to Award of Full Development Programme
more >>

 

 
xxHome

xx
About Nexus Oncology
xxExecutive Management
xxConsultant Medical Advisors
xxBoard of Directors

xxServices
xxWorking with Nexus Oncology
xx
Useful Links

xxExperience
xxTherapeutic Approaches
xxTumour-type Experience
xxProject Experience
> Case Studies

xxNewsroom

xxContact Nexus Oncology
xxMeet Nexus Oncology
xxVacancies

     
© Nexus Oncology 2010xxIxxwebsite credits